Sodium phenylbutyrate (Relyvrio component) structure · mechanism

Sodium phenylbutyrate (Relyvrio component) 2D structure

Role

Drug

Family

ALS neuroprotectant series

Mechanism class

ALS

Parent scaffold

Aminobenzothiazole core

Indication

ALS (Relyvrio) — confirmatory failure → withdrawal · FDA (withdrawn)

Structure source

Catalog seed

FDA / EMA

FDA (withdrawn)

ClinicalTrials.gov

AMX0035 ALS

Regulatory status

Withdrawn · FDA (withdrawn) · ClinicalTrials.gov · ClinicalTrials.gov

How similarity is calculated

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Methodology